Public access

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ...

The Lancet 395 (10241), 1907-1918, 2020

Mandates: US National Institutes of Health, Fonds de recherche du Québec - Santé

[HTML] cell.com

Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy

JG Lohr, P Stojanov, SL Carter, P Cruz-Gordillo, MS Lawrence, D Auclair, ...

Cancer cell 25 (1), 91-101, 2014

Mandates: US National Institutes of Health, Howard Hughes Medical Institute

[HTML] nejm.org

TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes

JS Welch, AA Petti, CA Miller, CC Fronick, M O’Laughlin, RS Fulton, ...

New England Journal of Medicine 375 (21), 2023-2036, 2016

Mandates: US National Institutes of Health

A phase 1/2 study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myeloma

AJ Jakubowiak, D Dytfeld, KA Griffith, D Lebovic, DH Vesole, S Jagannath, ...

Blood, The Journal of the American Society of Hematology 120 (9), 1801-1809, 2012

Mandates: US National Institutes of Health

A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia

GL Uy, MP Rettig, IH Motabi, K McFarland, KM Trinkaus, LM Hladnik, ...

Blood, The Journal of the American Society of Hematology 119 (17), 3917-3924, 2012

Mandates: US National Institutes of Health

Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium

P Grivas, AR Khaki, TM Wise-Draper, B French, C Hennessy, CY Hsu, ...

Annals of oncology 32 (6), 787-800, 2021

Mandates: US National Institutes of Health, Fonds de recherche du Québec - Santé

[PDF] jamanetwork.com

Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19

MA Thompson, JP Henderson, PK Shah, SM Rubinstein, MJ Joyner, ...

JAMA oncology 7 (8), 1167-1175, 2021

Mandates: US National Institutes of Health, US Assistant Secretary for Preparedness …

Maintenance therapy with decitabine after allogeneic stem cell transplantation for acute myelogenous leukemia and myelodysplastic syndrome

I Pusic, J Choi, MA Fiala, F Gao, M Holt, AF Cashen, R Vij, CN Abboud, ...

Biology of Blood and Marrow Transplantation 21 (10), 1761-1769, 2015

Mandates: US National Institutes of Health

A phase 2 study of high-dose lenalidomide as initial therapy for older patients with acute myeloid leukemia

TA Fehniger, GL Uy, K Trinkaus, AD Nelson, J Demland, CN Abboud, ...

Blood, The Journal of the American Society of Hematology 117 (6), 1828-1833, 2011

Mandates: US National Institutes of Health

Risk of marrow neoplasms after adjuvant breast cancer therapy: the national comprehensive cancer network experience

AC Wolff, AL Blackford, K Visvanathan, HS Rugo, B Moy, LJ Goldstein, ...

Journal of clinical oncology 33 (4), 340-348, 2015

Mandates: US National Institutes of Health, Susan G. Komen

[HTML] ashpublications.org

Prognostic significance of FDG-PET in relapsed or refractory classical Hodgkin lymphoma treated with standard salvage chemotherapy and autologous stem cell transplantation

JP Smeltzer, AF Cashen, Q Zhang, A Homb, F Dehdashti, CN Abboud, ...

Biology of Blood and Marrow Transplantation 17 (11), 1646-1652, 2011

Mandates: US National Institutes of Health

Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission

A Rashidi, M Hamadani, MJ Zhang, HL Wang, H Abdel-Azim, M Aljurf, ...

Blood advances 3 (12), 1826-1836, 2019

Mandates: US Department of Defense, US National Institutes of Health, Patient-Centered …

A meta-analysis of patients receiving allogeneic or autologous hematopoietic stem cell transplant in mycosis fungoides and Sezary syndrome

PA Wu, YH Kim, PW Lavori, RT Hoppe, KE Stockerl-Goldstein

Biology of Blood and Marrow Transplantation 15 (8), 982-990, 2009

Mandates: US National Institutes of Health

Multidimensional analyses of donor memory-like NK cells reveal new associations with response after adoptive immunotherapy for leukemia

MM Berrien-Elliott, AF Cashen, CC Cubitt, CC Neal, P Wong, JA Wagner, ...

Cancer discovery 10 (12), 1854-1871, 2020

Mandates: US National Institutes of Health, V Foundation, USA

Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: a Center for International Blood and Marrow …

P Armand, HT Kim, MJ Zhang, WS Perez, PS Dal Cin, TR Klumpp, ...

Biology of Blood and Marrow Transplantation 18 (2), 280-288, 2012

Mandates: US National Institutes of Health

NCCN guidelines insights: multiple myeloma, version 3.2016

KC Anderson, M Alsina, D Atanackovic, JS Biermann, JC Chandler, ...

Journal of the National Comprehensive Cancer Network 14 (4), 389-400, 2016

Mandates: US National Institutes of Health

Systemic IL-15 promotes allogeneic cell rejection in patients treated with natural killer cell adoptive therapy

MM Berrien-Elliott, M Becker-Hapak, AF Cashen, M Jacobs, P Wong, ...

Blood, The Journal of the American Society of Hematology 139 (8), 1177-1183, 2022

Mandates: US National Institutes of Health, V Foundation, USA

Mobilization of allogeneic peripheral blood stem cell donors with intravenous plerixafor mobilizes a unique graft

MA Schroeder, MP Rettig, S Lopez, S Christ, M Fiala, W Eades, FA Mir, ...

Blood, The Journal of the American Society of Hematology 129 (19), 2680-2692, 2017

Mandates: US National Institutes of Health